Psychiatry / mental health clinical trials recruiting in Illinois

72 recruiting psychiatry / mental health trials match in Illinois. Showing 20.

• A Study to Evaluate the Efficacy and Safety of Esketamine for Reduction of Symptoms of Major Depressive DisorderRecruiting

  Phase 3 · Janssen Research & Development, LLC · Evanston, Illinois

• "A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder"Recruiting

  Phase 3 · Cybin IRL Limited · Chicago, Illinois

• Randomized Withdrawal Study in Patients With SchizophreniaRecruiting

  Phase 3 · Vanda Pharmaceuticals · Chicago, Illinois

• Developing Evidence-Based Cognitive Approaches to Improve Adjustment to Vision LossRecruiting

  N/A · The Chicago Lighthouse · Chicago, Illinois

• A Study to Evaluate the Effect of KarXT on Urological SafetyRecruiting

  Phase 4 · Bristol-Myers Squibb · Chicago, Illinois

• My Wellbeing Guide: A Novel Tool for Managing Stress and Improving Quality of LifeRecruiting

  N/A · Northwestern University · Chicago, Illinois

• Study to Assess Adverse Events and Change in Disease Activity When Oral ABBV-932 is Added to Antidepressant Therapies in Adult Participants With Generalized Anxiety DisorderRecruiting

  Phase 2 · AbbVie · Chicago, Illinois

• A Study of the Feasibility, Safety and Tolerability of Aticaprant as Adjunctive Treatment in Participants With SchizophreniaRecruiting

  Phase 1 · Janssen Research & Development, LLC · Chicago, Illinois

• A Trial of the Efficacy and Safety of SEP-363856 in Acutely Psychotic Participants With SchizophreniaRecruiting

  Phase 3 · Otsuka Pharmaceutical Development & Commercialization, Inc. · Chicago, Illinois

• Safety and Tolerability Trial of Lumateperone in Pediatric Patients With Schizophrenia, Bipolar Disorder or Autism Spectrum DisorderRecruiting

  Phase 3 · Intra-Cellular Therapies, Inc. · Naperville, Illinois

• Impact of Serial Bedside Video Calls on Stress Level in Parents of Infants Admitted to NICURecruiting

  N/A · Cook County Health · Chicago, Illinois

• A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive DisorderRecruiting

  Phase 3 · Cybin IRL Limited · Chicago, Illinois

• A Randomized Study of Azetukalner Versus Placebo in Major Depressive DisorderRecruiting

  Phase 3 · Xenon Pharmaceuticals Inc. · Chicago, Illinois

• Study of ABX-002 for the Adjunctive Treatment of Major Depressive Disorder (AMPLIFY)Recruiting

  Phase 2 · Autobahn Therapeutics, Inc. · Birmingham, Alabama

• Fostering Optimal Regulation of Emotion for Prevention of Secondary Trauma (FOREST)Recruiting

  N/A · Northwestern University · Chicago, Illinois

• Safety and Efficacy of Brilaroxazine (RP5063) in SchizophreniaRecruiting

  Phase 3 · Reviva Pharmaceuticals · Chicago, Illinois

• A Study to Evaluate the Long-term Safety and Tolerability of KarXT and KarX-EC for the Treatment of Schizophrenia and Autism-Related Irritability in Adolescents, RespectivelyRecruiting

  Phase 3 · Karuna Therapeutics, Inc., a Bristol Myers Squibb company · Chicago, Illinois

• Effects of Walking in Greenspace and the Built Environment in Adults With Prediabetes: A Randomized Crossover TrialRecruiting

  N/A · University of Minnesota · Lake Forest, Illinois

• A Study to Evaluate TNX-102 SL Monotherapy Versus Placebo in Participants With Major Depressive Disorder (MDD)Recruiting

  Phase 2 · Tonix Pharmaceuticals, Inc. · Orlando, Florida

• Study of ITI-1284 as Monotherapy Treatment in Patients With Generalized Anxiety DisorderRecruiting

  Phase 2 · Intra-Cellular Therapies, Inc. · Birmingham, Alabama

Source: ClinicalTrials.gov. Recruitment status changes often — confirm on each study page.